Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and... see more

TSXV:THRM - Post Discussion

Therma Bright Inc > It occurs to me
View:
Post by Bakunin6 on May 21, 2021 12:23pm

It occurs to me

That we don't need hc or fda approval to sell in asia.
Perhaps that's why the k-one tone was full speed ahead...
With our primary Asia-based manufacturing partner, K-One MediTech, in place we are ready to begin production of our CE-approved AcuVid™ COVID-19 Rapid Antigen Saliva Test....and
 K-One MediTech will be granted the primary manufacturer rights for Asia of the Company's AcuVid™ COVID-19 Rapid Antigen Saliva Test Kits for a period of two (2) years commencing from the 1st production batch for the commercial market
Comment by stockmonster6 on May 21, 2021 2:20pm
Correct. Those approvals are only for USA and Canada. They are good stamps of approval, especially FDA, but are not what is required in Asia.
Comment by forrest6748 on May 21, 2021 2:42pm
But don't,t forget for the FDA:This wil surely help.. K-One Meditech, an ISO 13485 certified company, is a well-established medical device manufacturer registered with the FDA to supply medical devices and products
Comment by TheeRook on May 21, 2021 3:17pm
They are not  into testing devices.  This is all new for them so that is why no production until the 4Q. Currently  K-One is a Medical Supplies Provider We manufacture and distribute nasal swabs, ventilators and syringe safety needle caps to the healthcare industry. Which all have to be FDA approved to be sold in the USA. Medkaire Ventilator is manufactured by K-One under ...more  
Comment by Bakunin6 on May 21, 2021 3:21pm
Im thinking they're going to start making them now for asian distribution. If it works, it works...why wouldn't they? what's stopping them? 
Comment by TheeRook on May 21, 2021 3:25pm
Approval. Each country has their own Medical Device Authority (MDA) Even in Malayasia  what they make has to be approved before commercial sale.
Comment by TheeRook on May 21, 2021 3:49pm
THRm ACUVid is still  missing the Limit of Detection,   PERFORMANCE CHARACTERISTICS and CLINICAL PERFORMANCE   data from their published information. Take a look at  the FDa Approved BinaxNOW™ COVID-19 Ag Card to see what is missing. https://www.fda.gov/media/141570/download
Comment by Skipabeat22 on May 21, 2021 5:17pm
This could be why the results for Brazil are taking longer as they are putting all the data together to have a package to submit to the different Health Authorities in their respective countries.
Comment by Smokey1958 on May 22, 2021 7:26pm
I don't know what your problem is TheeRock but THRM has been very clear on their results. In fact the results as presented on their website are conservative compared to what they appear to have achieved recently. If you were to look, which you're not, at all the evidence both with THRM and those countries that have enbraced rapid antigen testing, you would see that THRM is on track to ...more  
Comment by Boudi1959 on May 23, 2021 6:40pm
Correct Smokey1958, he always appears when something is happening Just to leave people doubting! 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities